Prospective immune biomarker identification trial for renal cell carcinoma treatment.

Prospective immune biomarker identification trial for renal cell carcinoma treatment. - Prospective trial for renal cell carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047119

Enrollment

100

Registered

2022-04-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who would undergo treatment.

Exclusion criteria

Exclusion criteria: Minors

Design outcomes

Primary

Measure	Time frame
Identification of immune factors which correlates with outcomes.	—

Secondary

Measure	Time frame
Identification of immune factors which correlates with clinical factors.	—

Countries

Japan

Contacts

Public ContactRyuichi Mizuno

Keio University, school of medicine Urology

mizunor@z7.keio.jp0333531211

Outcome results